Delivery Order HHSN261201200033I-HHSN26100007
Award Date 7/1/15
Potential Completion Date 3/31/17
Potential Value $261K
Federal Agency
Ultimate Awardee
NAICS Category
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Cost No Fee
Place of Performance
Madison, WI 53715, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The National Cancer Institute issued a delivery order to the University of Wisconsin System on September 24, 2015, under the Cancer Prevention Agent Development Program 2012-2017 IDIQ for core infrastructure support related to early-phase clinical research in cancer prevention agent development, with a ceiling value of $4,057,707.83. Place of performance is Madison, Wisconsin. The order is cost-no-fee and has an ultimate completion date of September 23, 2019. No set-aside applies to this...
- <p>The National Cancer Institute issued a delivery order to the University of Wisconsin System on September 20, 2013, with a ceiling value of $559,231, under the Cancer Prevention Agent Development Program 2012-2017 for a Phase IIA cancer chemoprevention biomarker study of intermittent erlotinib in subjects with bladder cancer.</p> <p>Place of performance is Madison, Wisconsin. The order is cost, no fee, and runs through September 30, 2018. No set-aside was used.</p>
- The National Cancer Institute issued a delivery order to the University of Wisconsin System on September 24, 2013, with a ceiling value of $572,545.00 under the Cancer Prevention Agent Development Program 2012-2017 for a Phase II exploratory, randomized, placebo-controlled trial of pomegranate fruit extract in subjects with clinically localized prostate cancer undergoing active surveillance. Place of performance is Madison, Wisconsin. The order ultimate completion date is September 23, 2019....
- This federal contract award was made by the National Cancer Institute (NCI), a civilian agency within the U.S. Department of Health and Human Services, to the University of Wisconsin - Madison, operating as Research and Sponsored Programs within the University of Wisconsin System. The $418,872.19 contract is for research and development related to the Cancer Prevention Agent Development Program, which is focused on early phase clinical research. This contract is a delivery order under the Cancer...
- The National Cancer Institute (NCI) awarded a $1,366,178.15 delivery order contract to the University of Wisconsin System to conduct a pilot study of daily exemestane in women with complex atypical hyperplasia of the endometrium/endometrial intraepithelial neoplasia or grade 1 endometrial cancer. This contract is part of the NCI's Cancer Prevention Agent Development Program, which focuses on early-phase clinical research. The contract does not have a set-aside designation and will run through...
- <p>The National Cancer Institute issued a delivery order to Northwestern University on September 24, 2015, under the Cancer Prevention Agent Development Program 2012-2017 IDIQ for core infrastructure support and early-phase clinical research in cancer prevention agent development, with a ceiling value of $3,544,085.97.</p> <p>Place of performance is Chicago, IL. The order carries an ultimate completion date of April 30, 2021 and is priced on a cost-no-fee basis. No set-aside was used.</p>
- This is a federal contract award from the National Cancer Institute (NCI), a civilian agency within the U.S. government, to the University of Wisconsin System. The $1,214,305 contract is for a Phase I clinical trial to evaluate the safety and immunogenicity of a DNA plasmid-based vaccine (WOKVAC) that targets three breast cancer antigens (IGFBP-2, HER2, and IGF-IR). The contract is part of NCI's Cancer Prevention Agent Development Program, which focuses on early-stage clinical research. The...
- The Medical College of Wisconsin, Inc. was awarded a firm fixed price delivery order valued at six hundred twenty-nine thousand one hundred fifteen dollars and seventy cents ($629,115.70) by the National Cancer Institute, a component of the National Institutes of Health within the Department of Health and Human Services. The delivery order was issued against the PREVENT Cancer Program master indefinite-delivery/indefinite-quantity contract vehicle to support the PRECLINICAL PREVENT CANCER...
- The National Cancer Institute issued a purchase order to the University of Wisconsin System for $34,664.22 on September 9, 2015, for statistical modeling expertise and support to the Kentucky Tumor Registry. Work includes developing statistical methods to estimate confidence intervals for ranking composite health indexes and supporting the Kentucky Cancer Burden Index ranking project. Place of performance is Bethesda, Maryland. The order carries a firm fixed price, concludes by September 8,...
- This is a definitive contract awarded by the National Cancer Institute (NCI), a civilian agency of the Department of Health and Human Services (HHS), to the University of Wisconsin Hospitals and Clinics Authority (UWHCA) on September 15, 1999. The contract, valued at $2,765,970.00, is for a randomized controlled Phase II clinical trial to study the modulation of intermediate endpoint biomarkers, as described in Workstatement No. 61. The contract does not have a set-aside designation and is...